Cricut (NASDAQ: CRCT) CEO trims stake in 180,000-share planned sale
What happened Ashish Arora, Cricut, Inc. (NASDAQ: CRCT) chief executive officer, director and 10% owner, sold 180,000 shares from 2026-10-21 to 2026-10-23. The shares sold for $6.26 to $6.32 each and brought in about $1.13 million. The filing breaks the sale into three 60,000-share trades on 2026-10-21, 2026-10-22 and 2026-10-23, with weighted-average prices of $6.3098, […]
Elevance (NYSE: ELV) CFO trims stake 34.7% in insider stock sale
What happened Elevance Health, Inc. (NYSE: ELV) said EVP & CFO Mark Kaye sold 10,584 shares on 2026-10-22. The Form 4 lists 13 common-stock sales executed in multiple trades, with weighted-average prices from $434.00 to $447.19 per share. The report was filed on 2026-10-23. After the trades, Kaye held 19,919 shares in direct ownership. The […]
Roivant’s Venker trims stake under a prearranged trading plan (NASDAQ: ROIV)
What happened Roivant Sciences Ltd. (NASDAQ: ROIV) said Eric Venker sold 200,000 shares on 2026-10-20. The filing shows prices from $35.09 to $35.42 per share, for about $7.02 million in total. The form breaks the sale into two blocks. It shows 185,856 shares sold at a weighted average $35.09 and 14,144 shares at $35.42. After […]
United Therapeutics (NASDAQ: UTHR) CEO sells shares in prearranged plan
What happened United Therapeutics Corp (NASDAQ: UTHR) said Martine A. Rothblatt sold 9,500 shares on 2026-10-22. Rothblatt is the chairperson, CEO and a director. The filing says the shares came from stock options exercised the same day and were sold under a Rule 10b5-1 trading plan. The options had a $117.76 exercise price. The shares […]
last updated on 26 Oct 08:50